首页> 外文期刊>Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA >IN A TWO-YEAR DOUBLE-BLIND RANDOMIZED CONTROLLED MULTICENTER STUDY, CHONDROITIN SULFATE WAS SIGNIFICANTLY SUPERIOR TO CELECOXIB AT REDUCING CARTILAGE LOSS WITH SIMILAR EFFICACYAT REDUCING DISEASE SYMPTOMS IN KNEE OSTEOARTHRITIS PATIENTS
【24h】

IN A TWO-YEAR DOUBLE-BLIND RANDOMIZED CONTROLLED MULTICENTER STUDY, CHONDROITIN SULFATE WAS SIGNIFICANTLY SUPERIOR TO CELECOXIB AT REDUCING CARTILAGE LOSS WITH SIMILAR EFFICACYAT REDUCING DISEASE SYMPTOMS IN KNEE OSTEOARTHRITIS PATIENTS

机译:在一项为期两年的双盲随机对照多中心研究中,硫酸软骨素明显优于塞来昔布,通过类似的药效减少了软骨损失,减少了膝部骨关节炎的疾病症状。

获取原文
获取原文并翻译 | 示例
           

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号